Central and deep renal tumors can be effectively ablated

Radiofrequency ablation outcomes with fiberoptic peripheral temperature monitoring

Marshall S. Wingo, Raymond J. Leveillee

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Background and Purpose: The "overtreatment" of incidental renal lesions with nephrectomy and a desire to reduce patient morbidity and preserve renal function resulted in the development of nephron-sparing surgical alternatives. As clinical experience accumulates with radiofrequency ablation (RFA), confidence in the oncologic effectiveness of the management method increases. Although many investigators describe RFA management success in small-to medium-sized renal tumors, hesitation is expressed when managing endophytic, central, or hilar lesions. Using RFA combined with peripheral real-time temperature monitoring, we have improved the management success rate for endophytic or centrally located renal masses. Patients and Methods: RFA was selected in small-to medium-sized (range 1.0-5.3 cm), solid, contrast-enhancing, renal masses. CT-RFA appropriate tumors were accessible percutaneously through the flank in a prone position in the CT gantry. Anterior tumors, in close proximity (2 cm) to an abdominal viscus or other vital structure, underwent laparoscopic radiofrequency ablation (Lap-RFA). Fiberoptic temperature monitors (400 μm) were placed percutaneously 5 mm beyond the tumor periphery. Irrespective of lesion size, depth, or location, RFA treatments were continued until all peripheral sensors registered higher than 60°C. Results: In 131 patients, 146 tumors were managed with RFA ablation at our institution; 41 (28%) tumors in 39 patients were classified as endophytic. The mean endophytic tumor size was 2.7 cm (range 1.0-5.0 cm). Mean follow-up was 29 months. Thirty-seven of 41 (90.2%) endophytic, hilar, or centrally located tumors were managed with a single RFA procedure. Two of four recurrences were managed with extirpative therapy. Two recurrences await repeat CT-RFA management. Conclusions: RFA with peripheral fiberoptic temperature monitoring provides a definitive management end point. Inadequate coverage of the tumor volume is immediately recognized in real time, which allows necessary treatment adjustments to be made. "Enhanced" RFA with peripheral temperature monitoring resulted in an improved single treatment success rate and boosted operator confidence in the management of endophytic, central, or hilar renal tumors.

Original languageEnglish
Pages (from-to)1261-1267
Number of pages7
JournalJournal of Endourology
Volume22
Issue number6
DOIs
StatePublished - Jun 1 2008
Externally publishedYes

Fingerprint

Kidney
Temperature
Neoplasms
Recurrence
Prone Position
Viscera
Nephrons
Therapeutics
Tumor Burden
Nephrectomy
Research Personnel
Morbidity

ASJC Scopus subject areas

  • Urology

Cite this

Central and deep renal tumors can be effectively ablated : Radiofrequency ablation outcomes with fiberoptic peripheral temperature monitoring. / Wingo, Marshall S.; Leveillee, Raymond J.

In: Journal of Endourology, Vol. 22, No. 6, 01.06.2008, p. 1261-1267.

Research output: Contribution to journalArticle

@article{587d4b798f0e49eba0c63301f32f3ad7,
title = "Central and deep renal tumors can be effectively ablated: Radiofrequency ablation outcomes with fiberoptic peripheral temperature monitoring",
abstract = "Background and Purpose: The {"}overtreatment{"} of incidental renal lesions with nephrectomy and a desire to reduce patient morbidity and preserve renal function resulted in the development of nephron-sparing surgical alternatives. As clinical experience accumulates with radiofrequency ablation (RFA), confidence in the oncologic effectiveness of the management method increases. Although many investigators describe RFA management success in small-to medium-sized renal tumors, hesitation is expressed when managing endophytic, central, or hilar lesions. Using RFA combined with peripheral real-time temperature monitoring, we have improved the management success rate for endophytic or centrally located renal masses. Patients and Methods: RFA was selected in small-to medium-sized (range 1.0-5.3 cm), solid, contrast-enhancing, renal masses. CT-RFA appropriate tumors were accessible percutaneously through the flank in a prone position in the CT gantry. Anterior tumors, in close proximity (2 cm) to an abdominal viscus or other vital structure, underwent laparoscopic radiofrequency ablation (Lap-RFA). Fiberoptic temperature monitors (400 μm) were placed percutaneously 5 mm beyond the tumor periphery. Irrespective of lesion size, depth, or location, RFA treatments were continued until all peripheral sensors registered higher than 60°C. Results: In 131 patients, 146 tumors were managed with RFA ablation at our institution; 41 (28{\%}) tumors in 39 patients were classified as endophytic. The mean endophytic tumor size was 2.7 cm (range 1.0-5.0 cm). Mean follow-up was 29 months. Thirty-seven of 41 (90.2{\%}) endophytic, hilar, or centrally located tumors were managed with a single RFA procedure. Two of four recurrences were managed with extirpative therapy. Two recurrences await repeat CT-RFA management. Conclusions: RFA with peripheral fiberoptic temperature monitoring provides a definitive management end point. Inadequate coverage of the tumor volume is immediately recognized in real time, which allows necessary treatment adjustments to be made. {"}Enhanced{"} RFA with peripheral temperature monitoring resulted in an improved single treatment success rate and boosted operator confidence in the management of endophytic, central, or hilar renal tumors.",
author = "Wingo, {Marshall S.} and Leveillee, {Raymond J.}",
year = "2008",
month = "6",
day = "1",
doi = "10.1089/end.2008.0135",
language = "English",
volume = "22",
pages = "1261--1267",
journal = "Journal of Endourology",
issn = "0892-7790",
publisher = "Mary Ann Liebert Inc.",
number = "6",

}

TY - JOUR

T1 - Central and deep renal tumors can be effectively ablated

T2 - Radiofrequency ablation outcomes with fiberoptic peripheral temperature monitoring

AU - Wingo, Marshall S.

AU - Leveillee, Raymond J.

PY - 2008/6/1

Y1 - 2008/6/1

N2 - Background and Purpose: The "overtreatment" of incidental renal lesions with nephrectomy and a desire to reduce patient morbidity and preserve renal function resulted in the development of nephron-sparing surgical alternatives. As clinical experience accumulates with radiofrequency ablation (RFA), confidence in the oncologic effectiveness of the management method increases. Although many investigators describe RFA management success in small-to medium-sized renal tumors, hesitation is expressed when managing endophytic, central, or hilar lesions. Using RFA combined with peripheral real-time temperature monitoring, we have improved the management success rate for endophytic or centrally located renal masses. Patients and Methods: RFA was selected in small-to medium-sized (range 1.0-5.3 cm), solid, contrast-enhancing, renal masses. CT-RFA appropriate tumors were accessible percutaneously through the flank in a prone position in the CT gantry. Anterior tumors, in close proximity (2 cm) to an abdominal viscus or other vital structure, underwent laparoscopic radiofrequency ablation (Lap-RFA). Fiberoptic temperature monitors (400 μm) were placed percutaneously 5 mm beyond the tumor periphery. Irrespective of lesion size, depth, or location, RFA treatments were continued until all peripheral sensors registered higher than 60°C. Results: In 131 patients, 146 tumors were managed with RFA ablation at our institution; 41 (28%) tumors in 39 patients were classified as endophytic. The mean endophytic tumor size was 2.7 cm (range 1.0-5.0 cm). Mean follow-up was 29 months. Thirty-seven of 41 (90.2%) endophytic, hilar, or centrally located tumors were managed with a single RFA procedure. Two of four recurrences were managed with extirpative therapy. Two recurrences await repeat CT-RFA management. Conclusions: RFA with peripheral fiberoptic temperature monitoring provides a definitive management end point. Inadequate coverage of the tumor volume is immediately recognized in real time, which allows necessary treatment adjustments to be made. "Enhanced" RFA with peripheral temperature monitoring resulted in an improved single treatment success rate and boosted operator confidence in the management of endophytic, central, or hilar renal tumors.

AB - Background and Purpose: The "overtreatment" of incidental renal lesions with nephrectomy and a desire to reduce patient morbidity and preserve renal function resulted in the development of nephron-sparing surgical alternatives. As clinical experience accumulates with radiofrequency ablation (RFA), confidence in the oncologic effectiveness of the management method increases. Although many investigators describe RFA management success in small-to medium-sized renal tumors, hesitation is expressed when managing endophytic, central, or hilar lesions. Using RFA combined with peripheral real-time temperature monitoring, we have improved the management success rate for endophytic or centrally located renal masses. Patients and Methods: RFA was selected in small-to medium-sized (range 1.0-5.3 cm), solid, contrast-enhancing, renal masses. CT-RFA appropriate tumors were accessible percutaneously through the flank in a prone position in the CT gantry. Anterior tumors, in close proximity (2 cm) to an abdominal viscus or other vital structure, underwent laparoscopic radiofrequency ablation (Lap-RFA). Fiberoptic temperature monitors (400 μm) were placed percutaneously 5 mm beyond the tumor periphery. Irrespective of lesion size, depth, or location, RFA treatments were continued until all peripheral sensors registered higher than 60°C. Results: In 131 patients, 146 tumors were managed with RFA ablation at our institution; 41 (28%) tumors in 39 patients were classified as endophytic. The mean endophytic tumor size was 2.7 cm (range 1.0-5.0 cm). Mean follow-up was 29 months. Thirty-seven of 41 (90.2%) endophytic, hilar, or centrally located tumors were managed with a single RFA procedure. Two of four recurrences were managed with extirpative therapy. Two recurrences await repeat CT-RFA management. Conclusions: RFA with peripheral fiberoptic temperature monitoring provides a definitive management end point. Inadequate coverage of the tumor volume is immediately recognized in real time, which allows necessary treatment adjustments to be made. "Enhanced" RFA with peripheral temperature monitoring resulted in an improved single treatment success rate and boosted operator confidence in the management of endophytic, central, or hilar renal tumors.

UR - http://www.scopus.com/inward/record.url?scp=46249110529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46249110529&partnerID=8YFLogxK

U2 - 10.1089/end.2008.0135

DO - 10.1089/end.2008.0135

M3 - Article

VL - 22

SP - 1261

EP - 1267

JO - Journal of Endourology

JF - Journal of Endourology

SN - 0892-7790

IS - 6

ER -